Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a One-Month diet shift diabetes biomarkers?

NCT ID NCT07800884

Knowledge-focused Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

Researchers at Indonesia University are studying how diet, body measurements, genetic profiles, and blood biomarkers relate to glucose levels in healthy adults. The trial includes 181 participants split into three groups: one follows a balanced diet, one follows a low-carbohydrate diet, and one receives no diet change. Over one month, researchers track changes in blood sugar, insulin, cholesterol, and other markers to see how these factors interact. The goal is to develop a risk prediction tool for diabetes based on dietary intake and health indicators.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Balanced diet or low-carbohydrate diet
What this could lead to
If it works, this could lead to a way to predict diabetes risk based on diet and health indicators, helping people prevent the disease.
What could go wrong
This is an early, observational-style study with a short one-month diet period, so results may not apply broadly or lead to immediate changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

181 people

The number who actually took part.

Started

Apr 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 59 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18-59 years * Participants must provide informed consent to participate in the study, which include dietary tracking, biometric testing, and adherence to the intervention program. * Participants must be available for the full duration of the study (one months) and able to comply with the scheduled meal plans and testing appointments. Exclusion Criteria: * Individuals with history of type 1 and 2 diabetes, autoimmune, thyroid disease, which may affect carbohydrate metabolism. * Individuals who have experienced major surgery in the past six months, as it might impact carbohydrate metabolism and the body's reaction to dietary modifications. * Individuals with eating disorders, given the potential risks associated with dietary changes and the focus on food intake and biometrics. * Individuals with allergies or intolerances to the ingredients used in the study's meal plans to prevent adverse health effects and ensure participant safety. * Individuals currently participating in other clinical trials that could influence the outcomes of this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus Diet interventions

Contacts and locations

Locations

  • Faculty of Medicine Universitas Trisakti

    Jakarta, DKI Jakarta, 11440, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.